Explore the Global Tumour Ablation Devices Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Tumour Ablation Devices Market

Key Insight

Radiofrequency ablation will lead tumour ablation devices sales through 2036 with 39.7% share of the product type segment in 2026, driven by rising cancer incidence and expanding clinical adoption of minimally invasive treatment approaches. The market was valued at USD 2.20 billion in 2025 and is expected to be worth USD 9.12 billion by 2036.

May 12, 2026

Anurag Sharma

250 Pages

Cite this Report

Tumour Ablation Devices Market

https://www.futuremarketinsights.com/reports/tumour-ablation-devices-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

AngioDynamics
Bioventus Inc. (Misonix Inc.)
Boston Scientific
Chongqing Haifu Medical Technology Co. Ltd
EDAP TMS SA
Johnson & Johnson Service Inc.
Medtronic plc
Mermaid Medical

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Tumour Ablation Devices Market

Key Players

Similar Industry Reports